Valuation Haemonetics Corporation
Stocks
HAE
US4050241003
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
21:00:03 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 118.28 USD | -2.48% |
|
-0.35% | +47.57% |
| 10-09 | Barrington Adjusts Price Target on Haemonetics to $140 From $118, Keeps Outperform Rating | MT |
| 10-08 | CSL to Transition US Plasma Centers to Haemonetics' Latest Plasmapheresis Platform | MT |
Company Valuation: Haemonetics Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 3,068 | 3,992 | 4,335 | 3,175 | 2,511 | 5,381 | - | - |
| Change | - | 30.13% | 8.58% | -26.76% | -20.89% | 114.29% | - | - |
| Enterprise Value (EV) 1 | 3,582 | 4,473 | 4,335 | 4,093 | 3,490 | 6,043 | 5,709 | 5,350 |
| Change | - | 24.89% | -3.1% | -5.58% | -14.71% | 73.14% | -5.54% | -6.28% |
| P/E | 71.5x | 35.3x | 37.3x | 19.1x | 26.4x | 29.8x | 26.2x | 22.7x |
| PBR | 4.09x | 4.88x | - | 3.71x | 3.21x | 5.06x | 3.94x | 3.18x |
| PEG | - | 0x | 16.71x | 0.4x | -0.7x | 0.3x | 1.9x | 1.5x |
| Capitalization / Revenue | 3.09x | 3.42x | 3.31x | 2.33x | 1.88x | 3.8x | 3.6x | 3.36x |
| EV / Revenue | 3.61x | 3.83x | 3.31x | 3.01x | 2.62x | 4.27x | 3.82x | 3.35x |
| EV / EBITDA | 12.6x | 14.7x | 11.7x | 9.67x | 7.93x | 13.4x | 11.6x | 9.46x |
| EV / EBIT | 19.1x | 20.5x | 15.7x | 12.5x | 10.3x | 16.4x | 14.3x | 12.2x |
| EV / FCF | - | - | 37.5x | 33.7x | 13.4x | 19.1x | 17x | 14.9x |
| FCF Yield | - | - | 2.66% | 2.96% | 7.46% | 5.25% | 5.87% | 6.69% |
| Dividend per Share 2 | - | - | - | - | - | 1 | - | - |
| Rate of return | - | - | - | - | - | 0.85% | - | - |
| EPS 2 | 0.84 | 2.24 | 2.29 | 3.31 | 2.05 | 3.963 | 4.507 | 5.21 |
| Distribution rate | - | - | - | - | - | 25.2% | - | - |
| Net sales 1 | 993.2 | 1,169 | 1,309 | 1,361 | 1,334 | 1,417 | 1,495 | 1,599 |
| EBITDA 1 | 284.9 | 304.7 | 370.1 | 423.3 | 440.1 | 452.5 | 491.8 | 565.6 |
| EBIT 1 | 187.1 | 218.4 | 276.5 | 326.3 | 338.5 | 368.2 | 399 | 440.2 |
| Net income 1 | 43.38 | 115.4 | 117.6 | 167.7 | 97.31 | 177.4 | 207.2 | 239.6 |
| Net Debt 1 | 514.1 | 481.4 | - | 918 | 979.1 | 662 | 327.1 | -31.34 |
| Reference price 2 | 60.02 | 79.13 | 85.35 | 63.19 | 54.04 | 118.28 | 118.28 | 118.28 |
| Nbr of stocks (in thousands) | 51,112 | 50,448 | 50,786 | 50,237 | 46,471 | 45,497 | - | - |
| Announcement Date | 10/05/22 | 11/05/23 | 09/05/24 | 08/05/25 | 07/05/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.84x | 4.27x | 13.35x | 0.85% | 5.38B | |
| 30.95x | 4.09x | 15.82x | 2.45% | 181B | |
| 20.26x | 3.52x | 12.59x | 2.99% | 116B | |
| 22.98x | 4.5x | 15.69x | 1.22% | 113B | |
| 27.35x | 2.68x | 10.75x | 2.64% | 79.83B | |
| 18.7x | 0.22x | 13.49x | 0.7% | 65.06B | |
| 31.17x | 7.75x | 19.98x | 1.28% | 54.35B | |
| 36.95x | 3.53x | 12.1x | 2.05% | 52.23B | |
| 37.95x | 9.42x | 26.36x | -.--% | 44.15B | |
| 34.57x | 6.06x | 19.03x | -.--% | 32.47B | |
| Average | 29.07x | 4.60x | 15.92x | 1.42% | 74.4B | |
| Weighted average by Cap. | 27.62x | 4.21x | 15.34x | 1.84% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- HAE Stock
- Valuation Haemonetics Corporation
Select your edition
All financial news and data tailored to specific country editions
